Stockreport

Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results

Vivani Medical, Inc.  (VANI) 
PDF Initiation of the NPM-115 clinical program expected in the fourth quarter of 2024 with a first-in-human study evaluating a miniature, subdermal GLP-1 (exenatide) implant [Read more]